To explore the function of autophagy inhibitors in 5-FU therapy, we established a xenograft mouse model in which four CRC patient-derived tissues (two with high expression of SHMT2 and two with low expression of SHMT2) were implanted subcutaneously (Fig. 6A–B). This evidence concerns the gene SHMT2 and colorectal carcinoma.